发明名称 |
BI-FUNCTIONAL CANCER TREATMENT AGENTS |
摘要 |
A novel fusion protein, comprising a receptor-antagonizing domain and a positive immunomodulator domain, characterized, for example, by its ability to block apoptosis and/or inhibit endocrine response, is useful in treating cancer. For example, a human prolactin antagonist-interleukin 2 (hPRLA-IL-2) fusion protein combines apoptosis induction and immuno-therapy to combat cancer in the breast or prostate.
|
申请公布号 |
WO0170985(A3) |
申请公布日期 |
2002.04.18 |
申请号 |
WO2001US09284 |
申请日期 |
2001.03.23 |
申请人 |
GREENVILLE HOSPITAL SYSTEM;CHEN, WEN, Y.;WAGNER, THOMAS, E. |
发明人 |
CHEN, WEN, Y.;WAGNER, THOMAS, E. |
分类号 |
A61K38/00;A61P35/00;C07K14/52;C07K14/55;C07K14/57;C07K14/575;C07K19/00;C12N15/16;C12N15/62;(IPC1-7):C12N15/16;A61K38/22 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|